Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON31361Phase 3Not yet recruiting
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Doxycycline with Placebo (2 arms). Primary endpoint: OMERACT-OARSI clinical response at week 24. Planned start Jul 2007; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON31361.